Results 81 to 90 of about 2,123,633 (258)
Zuranolone: A case study in (regulatory) rush to judgement?
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove +4 more
wiley +1 more source
Background In transitioning from the Millennium Development Goal to the Sustainable Development Goal era, it is imperative to comprehensively assess progress toward reducing maternal mortality to identify areas of success, remaining challenges, and frame
GBD 2015 Maternal Mortality Collaborators (7807730)
core +2 more sources
Severe Obstetric Morbidity: Prevalence, Risk Factors and Outcome
Background: Severe Obstetric Morbidity (SOM) can be a supple- mentary indicator to maternal mortality. We have very little in- formation about its prevalence and risk factors.
Reena RP, Umadevi N, Ajitha BK
doaj
Achieving the Millennium Development Goal of reducing maternal mortality in rural Africa: an experience from Burundi. [PDF]
OBJECTIVES: To estimate the reduction in maternal mortality associated with the emergency obstetric care provided by Médecins Sans Frontières (MSF) and to compare this to the fifth Millennium Development Goal of reducing maternal mortality.
Nicolai, M +16 more
core +1 more source
Background: Maternal mortality is a strong indicator for measuring the health care provided to the women by any society. Although pregnancy is considered physiological at times it leads to morbidity and even death.
Satyaprabha S1, Vivekananda A2, Mythreai3, Wilson V4
doaj
Abstract Aim Critical care for COVID‐19 patients presents unique challenges, particularly in sedation management. Patients demonstrate notable dose‐related resistance to propofol, potentially due to complex pharmacokinetic alterations. Emerging evidence suggests that plasma extracellular vesicle‐associated miRNA represents valuable predictive ...
Debora Curci +10 more
wiley +1 more source
Estimation and monitoring of mortality, across multiple population-periods, is vital to improving national and global health outcomes. Reducing maternal mortality is a key part of the Sustainable Development Goals (SGDs), which commit countries and ...
Emily N. Peterson +3 more
doaj +1 more source
Examining the ‘‘Urban Advantage’’ in maternal health care in developing countries [PDF]
As the global urban population surpasses the rural, continuing growth in most developing countries means an inevitable increase in urban births. The majority of births in many countries will not be in remote rural areas, but in towns and cities [1].
Osrin, David +18 more
core +1 more source
Aims This study aimed to improve the understanding of lithium's safety profile by analysing the frequency and distribution of reported adverse drug reactions (ADRs) compared to second‐generation antipsychotics (SGAs). Methods Individual case safety reports from VigiBase (1968–October 2023) involving individuals older than 2 years, with lithium or SGAs ...
Lisa T. Ringeling +8 more
wiley +1 more source
“Near Miss” Obstetric Events and Maternal Deaths in a Tertiary Care Hospital: An Audit
Objectives. (1) To determine the frequency of maternal near miss, maternal near miss incidence ratio (MNMR), maternal near miss to mortality ratio and mortality index. (2) To compare the nature of near miss events with that of maternal mortality.
Roopa PS +5 more
doaj +1 more source

